Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.
Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.
Braune SA, et al.
Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.
Crit Care Med. 2013.
PMID: 23660733